(3) Based solely on a report on Schedule 13G filed on February 8, 2024 which indicates that FMR LLC has sole voting and dispositive power over 5,355,867 shares of common stock. The principal address of FMR LLC is 245 Summer Street, Boston, Massachusetts 02210.
(4) Based solely on a report on Schedule 13G filed on February 12, 2026 which indicates that Blue Owl Capital Holdings LP has sole shared voting and dispositive power over 4,451,219 shares of common stock. The principal address of Blue Owl Capital Holdings LP is 399 Park Avenue, New York, New York 10022.
(5) Based solely on a report on Schedule 13G filed on December 8, 2025 which indicates that Janus Henderson Group PLC has sole shared voting and dispositive power over 3,750,000 shares of common stock. The principal address of Janus Henderson Group PLC is 201 Bishopsgate EC2M 3AE, United Kingdom.
(6) Consists of (i) 115,000 shares of common stock held directly by Michael J.M. Hitchcock, Ph.D., and (ii) 632,623 shares of our common stock that may be acquired pursuant to the exercise of stock options within 60 days of March 31, 2026.
(7) Consists of (i) 572,427 shares of common stock held directly by Rainer (Ramses) Erdtmann, (ii) 784,470 shares of Common Stock issuable within 60 days after March 31, 2026 upon the exercise of options held directly by Rainer (Ramses) Erdtmann, (iii) an aggregate of 210,000 shares of common stock held by the children of Rainer (Ramses) Erdtmann, (iv) 174,614 shares of common stock held by a trust with an independent trustee, or Trust 1, and (v) 1,134,989 shares of common stock held by a separate trust with an independent trustee, or Trust 2.
(8) Consists of 268,738 shares of our common stock that may be acquired pursuant to the exercise of stock options within 60 days of March 31, 2026.
(9) Consists of 110,792 shares of our common stock that may be acquired pursuant to the exercise of stock options within 60 days of March 31, 2026.
(10) Information herein is based solely on the Schedule 13G/A filed with the SEC on February 12, 2024 by Mr. Butler and on the Company’s records. Consists of (i) 2,493,407 shares of common stock held directly by Thomas Butler (ii) 228,470 shares of common stock held directly by Point Sur Investors Fund I, L.P., or Point Sur Investors Fund, and (iii) 252,320 shares of common stock held directly by Point Sur Investors, LLC, or Point Sur LLC. Point Sur LLC is the General Partner of Point Sur Investors Fund. Thomas Butler is the managing members of Point Sur LLC. As such, Mr. Butler has voting and dispositive power over the securities held by Point Sur Investors Fund and Point Sur LLC. The principal address for Point Sur Investors, LLC and Point Sur Investors Fund I, L.P. is 1073 Arlington Blvd., El Cerrito, California 94530. Mr. Butler’s role as Chief Executive Officer of the Company ended effective as of March 25, 2025.
(11) Consists of 121,066 shares of our common stock that may be acquired pursuant to the exercise of stock options within 60 days of March 31, 2026.
(12) Consists of 103,769 shares of our common stock that may be acquired pursuant to the exercise of stock options within 60 days of March 31, 2026.
(13) Consists of 66,993 shares of our common stock that may be acquired pursuant to the exercise of stock options within 60 days of March 31, 2026.
(14) Consists of (i) 2,207,030 shares held directly and indirectly by our current directors and executive officers, and (ii) 2,088,451 shares subject to options exercisable within 60 days of March 31, 2026.
DELINQUENT SECTION 16(a) REPORTS
Section 16(a) of the Exchange Act requires our directors, executive officers, and persons holding more than 10% of our common stock to report their initial ownership of the common stock and other equity securities and any changes in that ownership in reports that must be filed with the SEC. The SEC has designated specific deadlines for these reports, and we must identify in this proxy statement those persons who did not file these reports when due. During the year ended December 31, 2025, Rainer (Ramses) Erdtmann filed one Form 4 late with respect to a gift of 40,000 shares of our common stock to a charity and 30,000 shares of our common stock to his children on August 13, 2025.
Based solely on a review of reports furnished to us, or written representations from reporting persons, other than as disclosed above, we believe all directors, executive officers, and 10% owners timely filed all reports regarding transactions in our securities required to be filed for 2025 by Section 16(a) under the Exchange Act. In making this statement, we relied solely upon an examination of the copies of Forms 3, 4 and 5, and amendments thereto, provided to us and the written representations of our reporting persons.
REPORT OF THE AUDIT COMMITTEE
The audit committee is appointed by the board of directors to assist the board of directors in fulfilling its oversight responsibilities with respect to (1) the integrity of Biomea’s financial statements and financial reporting process and systems of internal controls regarding finance, accounting, and compliance with legal and regulatory requirements, (2) the qualifications, independence, and performance of Biomea’s independent registered public accounting firm, (3) the performance of Biomea’s internal audit function, if any, and (4) other matters as set forth in the charter of the audit committee approved by the board of directors.
Management is responsible for the preparation of Biomea’s financial statements and the financial reporting process, including its system of internal control over financial reporting and its disclosure controls and procedures. The independent registered public accounting firm is responsible for performing an audit of Biomea’s financial statements in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB) and issuing a report thereon. The audit committee’s responsibility is to monitor and oversee these processes.
In connection with these responsibilities, the audit committee reviewed and discussed with management and the independent registered public accounting firm the audited financial statements of Biomea Fusion, Inc. for the fiscal year ended December 31, 2025. The audit committee also discussed with the independent registered public accounting firm the matters required to be discussed by the PCAOB’s Auditing Standard No. 1301, Communication with Audit Committees. In addition, the audit committee received written communications from the independent registered public accounting firm confirming their independence as required by the applicable requirements of the PCAOB and has discussed with the independent registered public accounting firm their independence.
Based on the reviews and discussions referred to above, the audit committee recommended to the board of directors that the audited financial statements of Biomea Fusion be included in Biomea’s 2025 Annual Report on Form 10-K for the fiscal year ended December 31, 2025, that was filed with the SEC. The information contained in this report shall not be deemed to be (1) “soliciting material,” (2) “filed” with the SEC, (3) subject to Regulations 14A or 14C of the Exchange Act, or (4) subject to the liabilities of Section 18 of the Exchange Act. This report shall not be deemed incorporated by reference into any of our other filings under the Exchange Act or the Securities Act, except to the extent that we specifically incorporate it by reference into such filing.
THE AUDIT COMMITTEE OF THE
BOARD OF DIRECTORS OF BIOMEA
FUSION, INC.
Julianne Averill, M.S., Chairperson
Eric Aguiar, M.D.
Sumita Ray, J.D.
April 27, 2026